Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism CTSL inhibitors(Cathepsin L inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Atherosclerosis | Discovery | - | 15 Aug 2023 | |
Atherosclerosis | Discovery | - | 15 Aug 2023 | |
Endocrinology and Metabolic Disease | Discovery | - | 15 Aug 2023 | |
Endocrinology and Metabolic Disease | Discovery | - | 15 Aug 2023 | |
Infectious Diseases | Discovery | - | 15 Aug 2023 | |
Infectious Diseases | Discovery | - | 15 Aug 2023 | |
Other Diseases | Discovery | - | 15 Aug 2023 | |
Other Diseases | Discovery | - | 15 Aug 2023 | |
Skeletal Lesion | Discovery | - | 15 Aug 2023 | |
Skeletal Lesion | Discovery | - | 15 Aug 2023 |